Evidence map›Paper›PMID 11411458›Full record

ArticlePathology oncology research : POR2001

Poorly differentiated synovial sarcoma: a case report.

F Cappello, M Bellafiore, F Bucchieri, G Balsano, A Palma, G Zummo

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

F CappelloInstitute of Pathological Anatomy, University of Palermo, Italy. FRANCAPP@HOTMAIL.COM
M Bellafiore
F Bucchieri
G Balsano
A Palma
G Zummo
University of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poorly differentiated synovial sarcoma is a rare soft tissue tumor. We studied a case arising in the pleural cavity of a young subject, characterised by the presence of spindle cell, small cell, and large epithelioid cell areas. We performed stains for mucosubstances and analysed the expression of cytokeratins 5/6, 7, 8, 18, 19, CEA, CD34, Ber-Ep4 and calretinin to characterize the phenotype of this neoplasm. We furthermore assessed immunohistochemically the presence of p53, Bcl-2, Bax and caspase 3, four apoptotic markers, to evaluate a relationship between apoptotic activity and the behaviour of this tumor. Our findings showed a strong presence of calretinin, p53 and Bcl-2 in all three areas. The possibility that poorly differentiated synovial sarcoma could be calretinin-positive was a new data, to our knowledge, and it could be of some importance in diagnostic pathology. Moreover, the negligible positivity for Bax and caspase 3 suggested that the minor role of programmed cell death could be one of the causes of the aggressive behaviour of this tumor. These data also suggest that the reduction of apoptotic phenomena in poorly differentiated synovial sarcoma could be considered one of the major mechanisms of tumoral growth.

Indexed as

Adultbcl-2-Associated X ProteinBiomarkers, TumorCalbindin 2Caspase 3CaspasesHumansImmunoenzyme TechniquesMaleNeoplasm ProteinsPleural NeoplasmsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2S100 Calcium Binding Protein GSarcoma, SynovialTumor Suppressor Protein p53BAX protein, humanbcl-2-Associated X ProteinBiomarkers, TumorCALB2 protein, humanCalbindin 2CASP3 protein, humanCaspase 3CaspasesNeoplasm ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2S100 Calcium Binding Protein GTumor Suppressor Protein p53

Identifiers

PMID11411458
OpenAlexW2120141573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.